Literature DB >> 22860922

Pyrazine derivatives: a patent review (2008 - present).

Sabrina Baptista Ferreira1, Carlos Roland Kaiser.   

Abstract

INTRODUCTION: Pyrazines derivatives are well-known and important two-nitrogen-containing six-membered ring aromatic heterocyclic compounds and can carry substituents at one or more of the four ring carbon atoms. Pyrazines are a class of compounds that occur in nature and various methods have been worked out for their synthesis. A large number of pyrazine derivatives have been found to possess diverse pharmacological properties, which has caused an increasing interest by researchers in this core. AREA COVERED: This review provides a comprehensive review of the pyrazines derivatives patented between the years 2008 to 2012 as potential active compounds. The patent databases SciFinder and esp@cenet were used to locate patent applications that were published between 2008 to present. Information from articles published was also included. EXPERT OPINION: The diversity of pyrazines derivatives found in organisms in nature with different applications began to arouse the interest of research in this nucleus. The pyrazines derivatives have numerous prominent pharmacological effects, such as antibacterial, antifungal, antimycobacterial, anti-inflammatory, analgesic, anticancer for different types, antidiabetic, treatment for arteriosclerosis, antiviral. It's the time to conduct further studies aimed at rationalizing the biological activities found in order to develop more effective and clinically interesting compounds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22860922     DOI: 10.1517/13543776.2012.714370

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  5 in total

1.  When biomolecules meet 2-hydrazinopyrazine: from theory through experiment to molecular levels using a wide spectrum of techniques.

Authors:  Paulina Mech; Mariusz Makowski; Anna Kawiak; Agnieszka Chylewska
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

2.  In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.

Authors:  Dilip K Tosh; Amanda Finley; Silvia Paoletta; Steven M Moss; Zhan-Guo Gao; Elizabeth T Gizewski; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2014-11-25       Impact factor: 7.446

Review 3.  Recent progresses in marine microbial-derived antiviral natural products.

Authors:  Yun-Fei Teng; Li Xu; Mei-Yan Wei; Chang-Yun Wang; Yu-Cheng Gu; Chang-Lun Shao
Journal:  Arch Pharm Res       Date:  2020-11-21       Impact factor: 4.946

4.  Ultrafast cold-brewing of coffee by picosecond-pulsed laser extraction.

Authors:  Anna R Ziefuß; Tim Hupfeld; Sven W Meckelmann; Martin Meyer; Oliver J Schmitz; Wiebke Kaziur-Cegla; Lucie K Tintrop; Torsten C Schmidt; Bilal Gökce; Stephan Barcikowski
Journal:  NPJ Sci Food       Date:  2022-04-08

5.  Production of tetra-methylpyrazine using engineered Corynebacterium glutamicum.

Authors:  Thomas Eng; Yusuke Sasaki; Robin A Herbert; Andrew Lau; Jessica Trinh; Yan Chen; Mona Mirsiaghi; Christopher J Petzold; Aindrila Mukhopadhyay
Journal:  Metab Eng Commun       Date:  2019-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.